What Is Known And Objective: Free-floating thrombi in the right heart occur in a subset of patients with pulmonary embolism with high rates of mortality if untreated. Treatment of choice is controversial and likely patient specific as studies have failed to consistently show a significant difference in mortality between options.
Case Summary: We present a case of a 45-year-old female with a mobile right heart thrombus treated with ultra-slow, low-dose t-PA infusion in combination with heparin.
What Is New And Conclusion: Ultra-slow, low-dose infusion of t-PA may be an option for treatment of mobile intracardiac thrombi.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/jcpt.12626 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Dual mechanical valve thrombosis resolution through thrombolytics: a case series.
Eur Heart J Case Rep
September 2023
Division of Cardiology, Medstar Washington Hospital Center, 110 Irving St., NW, Washington, DC, USA.
Background: Prosthetic valve thrombosis (PVT) is a severe complication of mechanical valve replacement. Simultaneous thrombosis of multiple prosthetic valves is rare and is associated with worse outcomes. Treatment options include anticoagulation, thrombolysis, and redo operative valve replacement, with rare reports of adjunctive balloon valvuloplasty.
View Article and Find Full Text PDFTreatment of intracardiac thrombi using ultra-slow low-dose thrombolytic therapy: A case report.
Rev Port Cardiol
November 2023
Serviço de Medicina Intensiva, Centro Hospitalar Universitário de São João, Porto, Portugal.
Article Synopsis
- A 57-year-old man with a heart problem was taken to the ICU because he had serious blood clots.
- He was treated with a special slow medicine called alteplase that helped dissolve the blood clots over two days.
- After improving, he had heart surgery a month later, showing that this new treatment can be helpful for stubborn clots.
Low dose ultra-slow infusion thrombolytic therapy (LDUSITT) as an alternative option in a COVID-19 patient with free-floating right atrial thrombus: a case report and review of literature.
Thromb J
January 2023
Department of Cardiology, Mousavi Hospital, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
The hyper-coagulopathy nature of COVID-19 is a prevalent consequence among patients. Free-floating right atrial thrombi are a relatively rare finding and the optimal therapy is a therapeutic dilemma.We present a 37-year-old woman with acute dyspnea and fatigue.
View Article and Find Full Text PDFThrombolytic therapy for mechanical aortic valve thrombosis in pregnancy: case report.
Eur Heart J Case Rep
December 2022
Division of Cardiovascular Medicine, Knight Cardiovascular Institute, Oregon Health & Science University, 3161 SW Pavilion Loop, Mail Code: UHN62, Portland, OR 97239, USA.
Article Synopsis
- Mechanical heart valves in pregnant women pose a significant risk of thrombosis due to pregnancy-induced changes in blood coagulation, necessitating effective long-term anticoagulation strategies.
- A case study of a 23-year-old pregnant woman with a mechanical aortic valve demonstrated successful treatment of valve thrombosis using a low-dose, slow infusion of thrombolytic therapy, which restored normal valve function within 8 days.
- It is crucial for healthcare providers to educate pregnant patients on anticoagulation management and involve them in decision-making to minimize complications.
Critique of "Dramatical Response to Low Dose Ultra-Slow Infusion of Alteplase for Massive Mitral Mechanical Valve Thrombosis".
Anatol J Cardiol
October 2022
Department of Cardiology, Faculty of Health Sciences, Ardahan University, Ardahan, Turkey.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!